Category: St. Jude Medical
Noted cardiologist and frequent medtech critic Dr. Robert Hauser warns that doctors need more data on the safety and effectiveness before widely accepting Boston Scientific's newly acquired and FDA approved lead-free implantable defibrillator.
Frequent medtech challenger Dr. Robert Hauser offered some words of warning for physicians clamoring over Boston Scientific's (NYSE:BSX) wire-free implantable defibrillator: curb your enthusiasm.
Medical devices made a lot of headlines in 2012, and the word "layoffs" was in many of them.
The medical device industry had a lot of big stories during the last year, including tales of recalls, lawsuits and CEO swapping, but the single factor that drove more big headlines than any other was news of layoffs.
Some of the biggest companies in the industry announced significant cuts in 2012, amounting to about 7,000 reported layoffs, by some estimates.
Publicly traded medical device companies shed about 7,000 jobs in the 2012, representing 1.6% of the industry's U.S. jobs base.
High-ranking medical device makers cut about 7,000 American jobs in 2012, representing about 1.6% of the industry's total U.S. workforce, according to a Reuters report.
A recall of St. Jude Medical's Durata pacemaker lead is not likely and the downside of an FDA warning is already baked into the stock, Wall Street analysts tell MassDevice.com.
St. Jude Medical (NYSE:STJ) isn't likely to recall its next-generation Durata pacemaker leads despite a warning from the FDA, but the situation with the medical device company's flagship product could change any day, according to Wall Street analysts.
St. Jude Medical says it's enrolled the 1st patient in the Ilumien I clinical trial of its PressureWire Aeris fractional flow reserve device.
St. Jude Medical (NYSE:STJ) said the Ilumien I clinical trial of its PressureWire Aeris fractional flow reserve device is under way, with the 1st of 500 patients enrolled.
The study aims to show the best way to use optical coherence tomography during coronary angiography procedures using the PressureWire Aeris.
St. Jude Medical shareholders accuse the company and 3 executives of making false statements about the Durata defibrillator leads, which the plaintiffs say are prone to the same design flaws that led to the high-profile Riata recall.
Updated Dec. 13, 2012, at 3:30 p.m. with comment from St. Jude Medical.
A group of St. Jude Medical (NYSE:STJ) shareholders filed a lawsuit accusing the company and 3 executives of making "false and misleading statements" about the Durata heart implant wires.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.